Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial

Disclosure, or open communication, by female microbicide trial participants of their trial participation and use of an investigational HIV prevention drug to a sexual partner may affect participants' trial product usage behavior and contribute to poor adherence. With mixed results from recent m...

Descripción completa

Detalles Bibliográficos
Autores principales: Succop, Stacey M., MacQueen, Kathleen M., van Loggerenberg, Francois, Majola, Nelisile, Karim, Quarraisha Abdool, Karim, Salim S. Abdool
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Routledge 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4193265/
https://www.ncbi.nlm.nih.gov/pubmed/25285564
http://dx.doi.org/10.1080/09540121.2014.938014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4193265/
https://www.ncbi.nlm.nih.gov/pubmed/25285564
http://dx.doi.org/10.1080/09540121.2014.938014

Ejemplares similares